These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Investigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer's Agents: In Vitro and In Silico Approaches. Anwar S; Rehman W; Hussain R; Khan S; Alanazi MM; Alsaif NA; Khan Y; Iqbal S; Naz A; Hashmi MA Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513821 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives. Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279 [TBL] [Abstract][Full Text] [Related]
8. Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's. Sun ZQ; Tu LX; Zhuo FJ; Liu SX Bioorg Med Chem Lett; 2016 Feb; 26(3):747-750. PubMed ID: 26783181 [TBL] [Abstract][Full Text] [Related]
9. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors. Daoud I; Melkemi N; Salah T; Ghalem S Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032 [TBL] [Abstract][Full Text] [Related]
10. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors. Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577 [TBL] [Abstract][Full Text] [Related]
12. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors. Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety. Ghanei-Nasab S; Khoobi M; Hadizadeh F; Marjani A; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2016 Oct; 121():40-46. PubMed ID: 27214510 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents. Tehrani MB; Rezaei Z; Asadi M; Behnammanesh H; Nadri H; Afsharirad F; Moradi A; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M Chem Biodivers; 2019 Jul; 16(7):e1900144. PubMed ID: 31155827 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives. Kurt BZ; Gazioglu I; Sonmez F; Kucukislamoglu M Bioorg Chem; 2015 Apr; 59():80-90. PubMed ID: 25706320 [TBL] [Abstract][Full Text] [Related]